Vincent, Kathy and Rich explain the Jenner Institute's SARS-CoV-2 vaccine, the NIH decision to stop the Remdesivir study, and answer listener questions. Click arrow to play Download TWiV 613 (63 MB .mp3, 106 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv

https://youtu.be/A-sAs5XXvGM From the Nipah Virus International Conference in Singapore, Vincent speaks with Richard Hatchett, CEO of CEPI, about its mission to stimulate and accelerate the development of vaccines against emerging infectious diseases. Click arrow to play Download TWiV 612 (87 MB .mp3, 143 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes ...

Daniel Griffin provides a weekly clinical update on COVID-19, then Michael Schmidt discusses how dentistry can be safely practiced during a pandemic, followed by answers to listener questions. Click arrow to play Download TWiV 611 (87 MB .mp3, 143 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV!

The moment a preprint emerges describing a new patient isolate of SARS-CoV-2, with a change in the genome sequence, the world seems to explode with concern about a new viral 'strain'. I want to explain why such angst is misguided and in the process explain exactly what is a virus ...

by Gertrud U. Rey A small subset of people are more vulnerable to severe complications and death resulting from SARS-CoV-2 infection. What causes this vulnerability? An increasing body of evidence suggests that patients suffering from severe COVID-19 often have one or more pre-existing conditions (co-morbidities). In an effort to describe ...